Heart/Cardiovascular

The purpose of this study is to assess the effectiveness and safety of rivaroxaban compared with placebo (inactive medication), in reducing the risk of death, heart attack or stroke in participants with heart failure and significant coronary artery disease following an episode of decompensated heart failure.

Primary disease category: 

The Prehospital Resuscitation On Helicopter Study (PROHS) is a pragmatic, multicenter, prospective observational study of air ambulance-based prehospital resuscitation regimens currently utilized at the participating sites. Patients will be enrolled at participating sites that currently have blood products available on air ambulances and other sites that do not. This study will not change the current prehospital standard of care for resuscitation. The primary outcome will be 30 day in-hospital mortality and the primary unit of analysis will be the patient.

Primary disease category: 
Primary disease category: 
Secondary disease category(ies): 

You may qualify to participate if you are: Female, 55 years or older; Male, 50 years or older; have gout and a history of cardiac disease like stroke or heart attack or blood circulation problems.

Primary disease category: 
Secondary disease category(ies): 

Pages

Subscribe to RSS - Heart/Cardiovascular